Literature DB >> 12429816

Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases.

Nadia El Hilali1, Nuria Rubio, Mercedes Martinez-Villacampa, Jerónimo Blanco.   

Abstract

Noninvasive imaging should facilitate the analysis of changes in experimental tumors and metastases-expressing photoproteins and result in improved data consistency and experimental animal welfare. We analyzed quantitative aspects of noninvasive imaging of luciferase-labeled tumors by comparing the efficiency of noninvasive light detection with in vitro quantification of luciferase activity. An intensified charge coupled device video camera was used to noninvasively image luciferase-expressing human prostate tumors and metastases in nude mice, after ip inoculation of luciferin. Repeated imaging of anesthetized animals after intervening growth periods allowed monitoring of tumor and metastases development. Comparison of photon events recorded in tumor images with the number of relative light units from luminometric quantification of homogenates from the same tumors, revealed that the efficiency with which light escapes tumors is inversely related to tumor size and that intensified charge coupled device images alone are not sufficient for quantitative evaluation of tumor growth. However, a combined videometric and luminometric approach did allow quantification and was used to show the cytostatic effects of paclitaxel in three different human prostate tumors growing in nude mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429816     DOI: 10.1097/01.lab.0000036877.36379.1f

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  21 in total

Review 1.  In vivo optical imaging and dynamic contrast methods for biomedical research.

Authors:  Elizabeth M C Hillman; Cyrus B Amoozegar; Tracy Wang; Addason F H McCaslin; Matthew B Bouchard; James Mansfield; Richard M Levenson
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2011-11-28       Impact factor: 4.226

2.  An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.

Authors:  Xiwu Chen; Yan Su; Barbara Fingleton; Heath Acuff; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals.

Authors:  Yusuke Inoue; Arinobu Tojo; Rieko Sekine; Yasushi Soda; Seiichiro Kobayashi; Akiko Nomura; Kiyoko Izawa; Toshio Kitamura; Toshiyuki Okubo; Kuni Ohtomo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05       Impact factor: 9.236

4.  Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.

Authors:  Katherine N Gibson-Corley; Mary E Herndon; Bo Zhou; Yihan Sun; Elisabeth Gustafson-Wagner; Melissa Teoh-Fitzgerald; Frederick E Domann; Michael D Henry; Christopher S Stipp
Journal:  Mol Cancer Res       Date:  2013-09-03       Impact factor: 5.852

5.  Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.

Authors:  Karianne G Fleten; Kine M Bakke; Gunhild M Mælandsmo; Andreas Abildgaard; Kathrine Røe Redalen; Kjersti Flatmark
Journal:  Clin Exp Metastasis       Date:  2016-11-03       Impact factor: 5.150

6.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.

Authors:  Toni Celià-Terrassa; Oscar Meca-Cortés; Francesca Mateo; Alexia Martínez de Paz; Nuria Rubio; Anna Arnal-Estapé; Brian J Ell; Raquel Bermudo; Alba Díaz; Marta Guerra-Rebollo; Juan José Lozano; Conchi Estarás; Catalina Ulloa; Daniel Álvarez-Simón; Jordi Milà; Ramón Vilella; Rosanna Paciucci; Marian Martínez-Balbás; Antonio García de Herreros; Roger R Gomis; Yibin Kang; Jerónimo Blanco; Pedro L Fernández; Timothy M Thomson
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

7.  In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation.

Authors:  Cheong J Lee; Aaron C Spalding; Edgar Ben-Josef; Lidong Wang; Diane M Simeone
Journal:  Transl Oncol       Date:  2010-06-01       Impact factor: 4.243

8.  In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.

Authors:  Darlene E Jenkins; Shang-Fan Yu; Yvette S Hornig; Tony Purchio; Pamela R Contag
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 9.  Xenograft models of head and neck cancers.

Authors:  Daisuke Sano; Jeffrey N Myers
Journal:  Head Neck Oncol       Date:  2009-08-13

Review 10.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.